39.2 RANDOMIZED, CONTROLLED TRIAL OF INTRAVENOUS IMMUNOGLOBULIN FOR PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDERS ASSOCIATED WITH STREPTOCOCCAL INFECTIONS

2016 ◽  
Vol 55 (10) ◽  
pp. S60-S61
Author(s):  
Kyle A. Williams
Keyword(s):  
Randomized Controlled Trial ◽  
Intravenous Immunoglobulin ◽  
Controlled Trial ◽  
Neuropsychiatric Disorders ◽  
Streptococcal Infections ◽  
Randomized Controlled

Intravenous Immunoglobulin in Neonates With Rhesus Hemolytic Disease: A Randomized Controlled Trial

PEDIATRICS ◽  
2011 ◽  
Vol 127 (4) ◽  
pp. 680-686 ◽  
Author(s):  
V. E. H. J. Smits-Wintjens ◽  
F. J. Walther ◽  
M. E. A. Rath ◽  
I. T. M. Lindenburg ◽  
A. B. te Pas ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Intravenous Immunoglobulin ◽  
Controlled Trial ◽  
Hemolytic Disease ◽  
Randomized Controlled

scholarly journals MINDFULNESS TRAINING FOR CAREGIVERS OF ALZHEIMER PATIENTS: PRELIMINARY RESULTS OF A RANDOMIZED CONTROLLED TRIAL

2019 ◽  
Vol 3 (Supplement_1) ◽  
pp. S860-S860
Author(s):  
Miriam Hurtado Pomares ◽  
Daniel Mendialdua Canales ◽  
Paula Peral Gómez ◽  
Cristina Espinosa Sempere ◽  
Iris Juárez Leal ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Pilot Study ◽  
Controlled Trial ◽  
Neuropsychiatric Symptoms ◽  
Depression Scale ◽  
Neuropsychiatric Disorders ◽  
Anxiety And Depression ◽  
Control Group ◽  
Depression Symptoms ◽  
Randomized Controlled

Abstract Mindfulness Based Health Care (MBHC) provides meditation techniques that may help to mitigate negative impact of dementia caregiving. We conducted a pilot randomized controlled trial with two parallel groups including 42 caregivers of Alzheimer patients (21 pairs). MBHC group learned the practice of mindfulness meditation once a week through 8 classes; control group did not receive any therapy. Anxiety and depression symptoms were the primary outcomes assessed in two occasions, i.e. at baseline and the end of the program, using the Hospital Anxiety and Depression scale respectively. Neuropsychiatric disorders of Alzheimer patients were also measured with Neuropsychiatric Inventory-Questionnaire. The details of the randomized controlled trial were described in clinicaltrial.gov NCT03858283. In this abstract, we presented the results of a pilot study conducted with 42 caregivers. Robust linear regression using MM-type estimator was performed to evaluate the changes in neuropsychiatric disorders in patients and anxiety and depression symptoms in caregivers adjusting for Score of Scale Global Deterioration. We observed that, compared to the control group, the MBHC group showed a tendency to a reduction in the total score Neuropsychiatric Inventor (β=-5.20; CI 95%: -10.47; 0.07) and the depression symptoms in the caregivers (β=-2.30; CI 95%: -5.43; 0.83). However, no changes were observed in the anxiety symptoms of the caregivers. In conclusion, the results of this pilot study suggested a positive effective on the reduction of neuropsychiatric symptoms in patents as well as on the depression in the caregivers. Nevertheless, these findings should be confirmed in a further complete study.

Intravenous immunoglobulin maintenance treatment in myasthenia gravis: A randomized, controlled trial sample size simulation

2014 ◽  
Vol 50 (6) ◽  
pp. 999-1004 ◽  
Author(s):  
Christian Eienbröker ◽  
Florian Seitz ◽  
Anna Spengler ◽  
Heike Kurz ◽  
Maria Seipelt ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Myasthenia Gravis ◽  
Sample Size ◽  
Intravenous Immunoglobulin ◽  
Maintenance Treatment ◽  
Controlled Trial ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document